Corey P. Mallett - Concepedia

Author

Corey P. Mallett

Walter Reed Army Institute of Research ORCID

Also Known As

C MALLETT, C Mallett, C P Mallett, C. MALLETT, C. Mallett, C. P. Mallett, C.P. Mallett, Conn Mallett, Corey Mallett, Corey P Mallett

Publications

Citations

H-Index

Concepts

All Affiliations

Walter Reed Army Institute of Research GlaxoSmithKline (United States)GlaxoSmithKline (Belgium)Université Laval National Cancer Institute

About

Corey P. Mallett is an author at Walter Reed Army Institute of Research specializing in immunology, medicine, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	22	1K
2	Allergy	7	7	339
3	Natural Sciences	3	3	42
4	Health Sciences	1	1	39
5	Biochemistry	1	1	11

Corey P. Mallett

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge. Gregory M. Glenn, Tanya Scharton‐Kersten, Russell Vassell, PubMed VaccinationSystemic Ab ResponseMucosal VaccinationAllergyMicrobial Pathogens	1998	153
Cutting Edge: Transcutaneous Immunization with Cholera Toxin Protects Mice Against Lethal Mucosal Toxin Challenge Gregory M. Glenn, Tanya Scharton‐Kersten, Russell Vassell, The Journal of Immunology Systemic Ab ResponseImmunotoxicologyMicrobial PathogensLaboratory ImmunologyImmunology	1998	138
Safety and Immunogenicity of a Proteosome- <i>Shigella flexneri</i> 2a Lipopolysaccharide Vaccine Administered Intranasally to Healthy Adults Louis Fries, Andrew Montemarano, Corey P. Mallett, Infection and Immunity	2001	107
Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri serotype 2a infection Lillian L. Van De Verg, Corey P. Mallett, H H Collins, Infection and Immunity Acute Lung InjuryInflammatory Lung DiseaseCytokine ResponsesLung InflammationInnate Immune System	1995	97
A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice Raffael Nachbagauer, David Kinzler, Angela Choi, npj Vaccines	2016	92
Oseltamivir-Resistant Pandemic A/H1N1 Virus Is as Virulent as Its Wild-Type Counterpart in Mice and Ferrets Marie‐Ève Hamelin, Mariana Baz, Yacine Abed, PLoS Pathogens	2010	91
Evaluation of Shigella vaccine safety and efficacy in an intranasally challenged mouse model Corey P. Mallett, Lillian L. VanDeVerg, H H Collins, Vaccine VaccinationVaccine SafetyCross-protectionShigella Vaccine SafetyVaccine Development	1993	85
The Ig <i>kappa</i> L chain allelic groups among the <i>Ig kappa</i> haplotypes and <i>Ig kappa</i> crossover populations suggest a gene order. Lawrence A. D'Hoostelaere, Konrad Hüppi, Beverly A. Mock, The Journal of Immunology	1988	80
Intransal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection Corey P. Mallett, Thomas L. Hale, Robert W. Kaminski, Infection and Immunity VaccinationShigella InfectionPulmonary MucosaMucosal VaccinationLethal Pneumonia	1995	80
A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models Giulietta Maruggi, Corey P. Mallett, Jason W. Westerbeck, Molecular Therapy	2022	80

Page 1